MicroChips develops MEMS-based device for drug delivery

11/30/2007 | M.I.T. Technology Review

Bedford, Mass.-based MicroChips is using "microelectromechanical" systems in developing implantable devices for drug delivery and glucose-level monitoring. With the aid of MEMS and caps carved from silicon and glass, the company was able to produce a device it hopes will be able to deliver an osteoporosis drug automatically and also a glucose sensor that could detect hikes in blood-sugar levels.

View Full Article in:

M.I.T. Technology Review

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health